Literature DB >> 11964533

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.

Gregory M Lucas1, Kelly A Gebo, Richard E Chaisson, Richard D Moore.   

Abstract

OBJECTIVE: To assess the temporal association of changes in substance abuse with antiretroviral therapy use and adherence, HIV-1 RNA suppression, and CD4 cell count changes in patients attending an urban clinic.
DESIGN: Prospective cohort study.
METHODS: Six-hundred and ninety-five HIV-1-infected individuals, who completed two or more semi-annual standardized surveys and in whom antiretroviral therapy was indicated, were included in the analysis. Surveys addressed antiretroviral therapy use and adherence, and use of illicit drugs and alcohol. Substance abuse was defined as active heroin, cocaine, or heavy alcohol use in the 6 months preceding survey. The units of analysis were consecutive pairs of surveys (couplets) in individual participants. Couplets in which participants denied substance abuse in both surveys were compared to couplets in which participants switched from non-use to substance abuse, and couplets in which participants reported substance abuse in both surveys were compared to couplets where participants switched from substance abuse to non-use.
RESULTS: Switching from non-use to substance abuse was strongly associated with worsening antiretroviral therapy use and adherence, less frequent HIV-1 RNA suppression, and blunted CD4 cell increases, compared to remaining free of substance abuse. Alternatively, switching from substance abuse to non-use was strongly associated with improvements in antiretroviral therapy use and adherence, and HIV-1 treatment outcomes, compared to persisting with substance abuse.
CONCLUSIONS: This longitudinal study highlights the dynamic nature of substance abuse and its temporal association with the effectiveness of HIV-1 treatment in patients attending an inner-city clinic.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11964533     DOI: 10.1097/00002030-200203290-00012

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  148 in total

Review 1.  Human immunodeficiency virus-associated dementia: an evolving disease.

Authors:  Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor
Journal:  J Neurovirol       Date:  2003-04       Impact factor: 2.643

2.  Alcohol use accelerates HIV disease progression.

Authors:  Marianna K Baum; Carlin Rafie; Shenghan Lai; Sabrina Sales; John Bryan Page; Adriana Campa
Journal:  AIDS Res Hum Retroviruses       Date:  2010-05       Impact factor: 2.205

3.  Longitudinal patterns of illicit drug use, antiretroviral therapy exposure and plasma HIV-1 RNA viral load among HIV-positive people who use illicit drugs.

Authors:  Jiaming Liang; Ekaterina Nosova; Hudson Reddon; Seonaid Nolan; Eugenia Socías; Rolando Barrios; M-J Milloy
Journal:  AIDS       Date:  2020-07-15       Impact factor: 4.177

4.  Delivery of HIV prevention counseling by physicians at HIV medical care settings in 4 US cities.

Authors:  Lisa R Metsch; Margaret Pereyra; Carlos del Rio; Lytt Gardner; Wayne A Duffus; Gordon Dickinson; Peter Kerndt; Pamela Anderson-Mahoney; Steffanie A Strathdee; Alan E Greenberg
Journal:  Am J Public Health       Date:  2004-07       Impact factor: 9.308

5.  Update on mental health issues in patients with HIV infection.

Authors:  Natalia Vlassova; Andrew F Angelino; Glenn J Treisman
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

6.  Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.

Authors:  Frederick L Altice; Duncan Smith-Rohrberg Maru; R Douglas Bruce; Sandra A Springer; Gerald H Friedland
Journal:  Clin Infect Dis       Date:  2007-08-13       Impact factor: 9.079

7.  Prevalence of HIV Viral Load Suppression Among Psychiatric Inpatients with Comorbid Substance Use Disorders.

Authors:  D M Coviello; R Lovato; K Apostol; M M Eisenberg; D S Metzger; R Szucs-Reed; N Kiryankova-Dalseth; D Kelly; A Jackson; M Plano; M B Blank
Journal:  Community Ment Health J       Date:  2018-05-11

8.  The Association Between Changes in Alcohol Use and Changes in Antiretroviral Therapy Adherence and Viral Suppression Among Women Living with HIV.

Authors:  Nikita Barai; Anne Monroe; Catherine Lesko; Bryan Lau; Heidi Hutton; Cui Yang; Anika Alvanzo; Mary Elizabeth McCaul; Geetanjali Chander
Journal:  AIDS Behav       Date:  2017-07

9.  The Impact of Substance Use on Adherence to Antiretroviral Therapy Among HIV-Infected Women in the United States.

Authors:  Yuehan Zhang; Tracey E Wilson; Adebola Adedimeji; Daniel Merenstein; Joel Milam; Jennifer Cohen; Mardge Cohen; Elizabeth T Golub
Journal:  AIDS Behav       Date:  2018-03

10.  Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting.

Authors:  Brenden Joseph; Thomas Kerr; Cathy M Puskas; Julio Montaner; Evan Wood; M-J Milloy
Journal:  AIDS Care       Date:  2015-04-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.